Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.

Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK

Open source

DOI
10.1002/alz.71404
Published
2026 Apr
Container
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/alz.71404,
  title = {Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.},
  author = {Farrell C and Saini F and Beidas MM and Ryan NS and Strydom A and Wiseman FK},
  year = {2026},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.71404},
  url = {https://doi.org/10.1002/alz.71404}
}

RIS

TY  - JOUR
TI  - Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.
AU  - Farrell C
AU  - Saini F
AU  - Beidas MM
AU  - Ryan NS
AU  - Strydom A
AU  - Wiseman FK
PY  - 2026
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.71404
UR  - https://doi.org/10.1002/alz.71404
ER  - 

APA

C, F., F, S., MM, B., NS, R., A, S., & FK, W. (2026). Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71404

Source records